Hepatitis C
352 results
1 - 100
Hepatitis C
Hepatitis C- MICROBIOLOGY
- CLINICAL
- SITES OF INFECTION
- TREATMENT
- General comments
- Treatment-naive
- Treatment failures
- HIV/HCV co-infection
- Cirrhotic patients
- Chronic kidney disease patients
- Regimens NOT recommended
- Follow-up
- Experimental and Future HCV Treatment Options
- Prevention
- OTHER INFORMATION
- Basis for recommendation
- References
- Hepatitis Due to Infections other than Hepatitis A, B, C, D, or E
- Ribavirin
- Daclatasvir
- Simeprevir
- Simeprevir
Asenapine- Tasimelteon
- Interferon alfa
- Oteseconazole
- Hepatitis B (HBV) vaccines
- Hepatitis B (HBV) vaccines
- Cobicistat
- Cobicistat
- Oritavancin
Antipsychotics- Viekira Pak
- Viekira Pak
- Lorcaserin
- Hepatitis A
- Interferon alpha (ABX)
- Glecaprevir + Pibrentasvir
- Glecaprevir + Pibrentasvir
- Sofosbuvir + Ledipasvir
- Sofosbuvir + Ledipasvir
- Nirmatrelvir/Ritonavir
- Nirmatrelvir/Ritonavir
- Technivie
- Tipranavir
- Tipranavir
- Gepotidacin
- Hepatitis A vaccine (HAV)
- Hepatitis A vaccine (HAV)
- Nevirapine
- Nevirapine
- Dalbavancin
- Sofosbuvir + velpatasvir
- Sofosbuvir + velpatasvir
- Eravacycline
- Anidulafungin
- Bedaquiline
- Staging Liver Disease
- Isavuconazonium sulfate
Kelly Gebo, M.D.- Quinine
- Tigecycline
- Ribavirin
- Elbasvir/Grazoprevir
- Nelfinavir
- Elbasvir/Grazoprevir
- Nelfinavir
- Fluconazole
- Bictegravir
- Sofosbuvir
- Bictegravir
- Sofosbuvir
- Fluconazole